Fibronectin (1B9) Monoclonal Antibody , Cy5 Conjugated
- Size: 100ul
- Application: IF(IHC-P)
- Reactivity: Human, Mouse, Rat
- Predicted Reactivity:
-
Datasheet
Tech Support
PRODUCT DETAILS
SPECIFICATIONS |
|
|---|---|
|
PRODUCT NAME |
Fibronectin (1B9) Monoclonal Antibody , Cy5 Conjugated |
|
CONJUGATION |
Cy5 |
|
HOST |
Mouse |
| SOURCE |
KLH conjugated synthetic peptide derived from human Fibronectin |
| IMMUNOGEN RANGE |
2240-2280/2386 |
| CLONALITY |
Monoclonal |
| ISOTYPE |
IgG |
| CONCENTRATION |
1ug/ul |
| PURIFICATION |
Purified by Protein G. |
| STORAGE BUFFER |
Aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide. |
| STORAGE CONDITION |
Store at 4°C for 12 months. |
TARGET |
|
|---|---|
| GENE ID |
|
| SUBCELLULAR LOCATION |
|
| SYNONYMS |
Fibronectin; FN1; Cold-insoluble globulin; CIG |
| BACKGROUND |
Fibronectins bind cell surfaces and various compounds including collagen, fibrin, heparin, DNA, and actin. Fibronectins are involved in cell adhesion, cell motility, opsonization, wound healing, and maintenance of cell shape. Involved in osteoblast compaction through the fibronectin fibrillogenesis cell-mediated matrix assembly process, essential for osteoblast mineralization. Participates in the regulation of type I collagen deposition by osteoblasts. Anastellin binds fibronectin and induces fibril formation. This fibronectin polymer, named superfibronectin, exhibits enhanced adhesive properties. Both anastellin and superfibronectin inhibit tumor growth, angiogenesis and metastasis. Anastellin activates p38 MAPK and inhibits lysophospholipid signaling. |
| APPLICATION DILUTION |
IF(IHC-P)(1:50-200) |